Developing: Pharma companies present IRA cases in New Jersey court

TREN­TON, NJ — Four phar­ma­ceu­ti­cal com­pa­nies made their case against the In­fla­tion Re­duc­tion Act’s drug ne­go­ti­a­tions pro­vi­sions, ar­gu­ing that the pro­gram vi­o­lates sev­er­al con­sti­tu­tion­al rights, among oth­er items.

Bris­tol My­ers Squibb, No­var­tis, No­vo Nordisk and John­son & John­son’s Janssen gave co­or­di­nat­ed ar­gu­ments in New Jer­sey’s dis­trict court in their cas­es against the gov­ern­ment. The com­pa­nies col­lec­tive­ly mar­ket six of the first 10 drugs that are un­der ne­go­ti­a­tion.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.